Published on 1 Jun 2023 on Simply Wall St. via Yahoo Finance
Even after rising 12% this past week, Lyell Immunopharma (NASDAQ:LYEL) shareholders are still down...
Over the last month the Lyell Immunopharma, Inc. (NASDAQ:LYEL) has been much stronger than before, rebounding by 54%. But that doesn't change the fact that the returns over the last year have been less than pleasing. The cold reality is that the stock has dropped 31% in one year, under-performing the market.
On a more encouraging note the company has added US$87m to its market cap in just the last 7 days, so let's see if we can determine what's driven the one-year loss for shareholders.
View our latest analysis for Lyell Immunopharma